A
Angela Dispenzieri
Researcher at Mayo Clinic
Publications - 1212
Citations - 72269
Angela Dispenzieri is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Multiple myeloma & Amyloidosis. The author has an hindex of 117, co-authored 1107 publications receiving 60367 citations. Previous affiliations of Angela Dispenzieri include University of Rochester & Kyungpook National University Hospital.
Papers
More filters
Journal ArticleDOI
Clinical epidemiology and treatment patterns of patients with multicentric Castleman disease: results from two US treatment centres.
Don Robinson,M.W. Reynolds,Corey Casper,Angela Dispenzieri,Jessica Vermeulen,K Payne,Judy Schramm,Kay M. Ristow,M.P. Desrosiers,Karen Yeomans,Dana Y. Teltsch,Richard S. Swain,Thomas M. Habermann,Philip Rotella,Helgi van de Velde +14 more
TL;DR: This study provides new information on MCD population demographics, treatment patterns, and medical utilization, and a minimal US period prevalence rate is proposed.
Journal ArticleDOI
Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities
Nadine Abdallah,Patricia T. Greipp,Prashant Kapoor,Morie A. Gertz,Angela Dispenzieri,Linda B. Baughn,Martha Q. Lacy,Suzanne R. Hayman,Francis K. Buadi,David Dingli,Ronald S. Go,Yi L. Hwa,Amie Fonder,Miriam Hobbs,Yi Lin,Nelson Leung,Taxiarchis Kourelis,Rahma Warsame,Mustaqeem A. Siddiqui,John A. Lust,Robert A. Kyle,Leif Bergsagel,Rhett P. Ketterling,S. Vincent Rajkumar,Shaji Kumar +24 more
TL;DR: In this article, the authors evaluated the impact of chromosome 1q (+1q) on clinical characteristics, treatment response, and survival outcomes in patients diagnosed with multiple myeloma.
Journal ArticleDOI
Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach
Angela Baker,Esteban Braggio,Susanna Jacobus,Sungwon Jung,Dirk R. Larson,Terry M. Therneau,Angela Dispenzieri,Scott Van Wier,Gregory J. Ahmann,Joan Levy,Louise M. Perkins,Seungchan Kim,Kimberly J. Henderson,David H. Vesole,S. Vincent Rajkumar,Diane F. Jelinek,John D. Carpten,Rafael Fonseca +17 more
TL;DR: This study represents the first comprehensive comparisons of the frequency and distribution of molecular alterations in MM tumors between AA and EA patients and shows no significant difference in the frequency of high-risk disease based on gene expression profiling.
Journal ArticleDOI
Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma.
Francis K. Buadi,Ivana N. Micallef,S. M. Ansell,Luis F. Porrata,Angela Dispenzieri,Mary Elliot,Dennis A. Gastineau,Morie A. Gertz,Martha Q. Lacy,Mark R. Litzow,A Tefferi,David J. Inwards +11 more
TL;DR: Autologous stem-cell transplant can be safely performed in patients 60 years or older with chemotherapy sensitive relapsed or first partial remission NHL and the outcome may not be different from that of younger patients in terms of TRM and EFS.
Journal ArticleDOI
POEMS syndrome: 2021 Update on diagnosis, risk-stratification, and management
TL;DR: The diagnosis of POEMS syndrome is made with three major criteria, two of which must include polyradiculoneuropathy and clonal plasma cell disorder, and at least one of the minor criteria as mentioned in this paper.